Amrize (NYSE:AMRZ) CEO Buys 26,000 Shares of Stock

Key Points

• CEO Jan Philipp Jenisch bought 26,000 Amrize shares at an average price of $42.47, investing approximately $1.10 million and increasing his stake by 1.49% to 1.767 million shares. He also purchased an additional 4,000 shares at $42.50.
• Amrize shares recently traded at $43.90, near their 52-week low of $41.61 and below their 50-day and 200-day moving averages. The company’s latest quarterly earnings of $0.88 per share missed analysts’ $0.92 estimate.
• Analysts have a consensus “Hold” rating and an average price target of $56.38, while Amrize recently paid a quarterly dividend of $0.11 per share.

Amrize Ltd (NYSE:AMRZ - Get Free Report) CEO Jan Philipp Jenisch purchased 26,000 shares of Amrize stock in a transaction dated Wednesday, September 2nd. The stock was bought at an average price of $42.47 per share, for a total transaction of $1,104,220.00. Following the completion of the purchase, the chief executive officer owned 1,767,000 shares in the company, valued at $75,044,490. This represents a 1.49% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Jan Philipp Jenisch also recently made the following trade(s):

• On Wednesday, September 2nd, Jan Philipp Jenisch acquired 4,000 shares of Amrize stock. The shares were purchased at an average price of $42.50 per share, for a total transaction of $170,000.00.

Amrize Price Performance

AMRZ traded up $0.93 on Thursday, reaching $43.90. The stock had a trading volume of 2,977,262 shares, compared to its average volume of 3,261,551. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $24.28 billion, a price-to-earnings ratio of 20.25, a price-to-earnings-growth ratio of 0.95 and a beta of 0.04. Amrize Ltd has a fifty-two week low of $41.61 and a fifty-two week high of $65.94. The firm has a 50-day moving average of $48.88 and a 200-day moving average of $53.41.

Amrize (NYSE:AMRZ - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The business had revenue of $3.49 billion for the quarter. As a group, sell-side analysts anticipate that Amrize Ltd will post 2.74 EPS for the current year.

Amrize Announces Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 18th. Amrize's dividend payout ratio (DPR) is 20.28%.

Analysts Set New Price Targets

AMRZ has been the subject of a number of recent analyst reports. DA Davidson initiated coverage on shares of Amrize in a research report on Monday, August 24th. They set a "neutral" rating and a $50.00 target price for the company. Truist Financial restated a "hold" rating and issued a $48.00 price target (down from $65.00) on shares of Amrize in a research report on Tuesday, July 7th. Sanford C. Bernstein reaffirmed an "outperform" rating on shares of Amrize in a research note on Monday, June 22nd. Oppenheimer decreased their price objective on shares of Amrize from $68.00 to $65.00 and set an "outperform" rating for the company in a research report on Tuesday, July 21st. Finally, William Blair set a $40.00 target price on shares of Amrize in a research note on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Amrize presently has a consensus rating of "Hold" and an average target price of $56.38.

Institutional Investors Weigh In On Amrize

Hedge funds have recently added to or reduced their stakes in the business. MCF Advisors LLC acquired a new position in Amrize during the fourth quarter worth $27,000. Basepoint Wealth LLC bought a new position in shares of Amrize in the fourth quarter valued at $33,000. US Bancorp DE acquired a new position in shares of Amrize during the third quarter valued at about $38,000. Itau Unibanco Holding S.A. grew its holdings in shares of Amrize by 150.0% during the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company's stock valued at $41,000 after buying an additional 450 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its position in shares of Amrize by 141.3% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 847 shares of the company's stock worth $46,000 after acquiring an additional 496 shares in the last quarter.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source